LBAY vs. SBIO ETF Comparison

Comparison of Leatherback Long/Short Alternative Yield ETF (LBAY) to ALPS Medical Breakthroughs ETF (SBIO)
LBAY

Leatherback Long/Short Alternative Yield ETF

LBAY Description

The investment seeks capital appreciation and income. The fund is an actively-managed ETF that seeks to achieve its investment objective by purchasing long positions in securities believed to provide sustainable shareholder yield (defined as dividends plus buybacks plus debt paydowns) and taking short positions in securities expected to decline in price. It will generally have net exposure of 75% - 110% long. The fund's long positions are generally expected to be comprised of equity securities or depositary receipts, although long positions may also include investment-grade corporate bonds and convertible bonds. It is non-diversified.

Grade (RS Rating)

Last Trade

$27.15

Average Daily Volume

4,801

Number of Holdings *

55

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$36.84

Average Daily Volume

12,226

Number of Holdings *

84

* may have additional holdings in another (foreign) market
Performance
Period LBAY SBIO
30 Days 6.61% 10.83%
60 Days 1.61% 11.27%
90 Days 2.94% 10.60%
12 Months 2.10% 17.61%
0 Overlapping Holdings
Symbol Grade Weight in LBAY Weight in SBIO Overlap
LBAY Overweight 55 Positions Relative to SBIO
Symbol Grade Weight
BG D 5.57%
XOM B 5.32%
ORI A 4.99%
FIS B 4.96%
ICE A 4.69%
V F 4.55%
AWK A 4.42%
ZBH D 4.31%
LHX C 4.27%
NEM A 4.23%
AGNC C 4.2%
ABBV A 4.16%
PKG A 4.05%
APD D 3.97%
CMCSA C 3.92%
MMM A 3.65%
MDT C 3.62%
UNP B 3.37%
JNJ B 3.19%
MTN D 3.13%
MO C 3.0%
RIO F 3.0%
HP C 2.94%
KO B 2.87%
PCH C 2.78%
MSCI C 2.74%
SPGI C 2.73%
KDP B 2.69%
T B 2.54%
CARR B 2.48%
BKNG D 2.44%
LW F 1.91%
SOLV C 1.78%
COIN D -0.81%
DAL D -0.85%
VRT D -0.94%
DUOL F -0.95%
FIX C -0.98%
NFLX D -0.99%
CMG D -1.01%
BURL A -1.14%
IRM A -1.2%
DKS C -1.22%
SITE D -1.24%
SQ F -1.31%
AAPL B -1.34%
TSLA C -1.4%
DASH D -1.53%
EQIX C -1.57%
DLR C -1.68%
SF A -1.71%
OLLI C -1.74%
RCL C -1.76%
PLNT C -1.77%
BLK A -1.79%
LBAY Underweight 84 Positions Relative to SBIO
Symbol Grade Weight
KRYS B -4.0%
ALKS C -3.1%
RNA C -3.02%
CRNX C -2.81%
IMVT D -2.79%
CORT B -2.43%
MRUS D -2.36%
DNLI C -2.26%
ACLX C -2.26%
XENE C -2.18%
IDYA C -2.11%
ACAD D -2.07%
FOLD D -1.98%
CLDX C -1.93%
MORF B -1.86%
GERN C -1.81%
AGIO C -1.79%
PTCT D -1.72%
NTLA D -1.68%
VCEL C -1.67%
PTGX C -1.55%
CGON C -1.45%
SNDX C -1.37%
MIRM C -1.34%
ARVN F -1.33%
VERA D -1.32%
AKRO D -1.28%
IMCR F -1.28%
ZLAB D -1.26%
KROS C -1.24%
VRNA B -1.21%
GLPG D -1.19%
EWTX D -1.16%
BCRX C -1.06%
MNKD C -1.05%
KURA D -1.05%
RCUS D -0.94%
DAWN C -0.92%
XNCR F -0.88%
PRTA D -0.86%
LBPH C -0.83%
IRON D -0.74%
IRWD D -0.73%
VRDN C -0.7%
SPRY C -0.7%
ANAB C -0.66%
TARS F -0.62%
FDMT F -0.62%
PHVS F -0.61%
ETNB D -0.6%
COGT C -0.6%
LQDA D -0.58%
OLMA C -0.57%
ERAS C -0.56%
PLRX D -0.53%
AUPH D -0.53%
FLGT C -0.47%
MLYS D -0.44%
ARCT F -0.43%
GHRS D -0.43%
CELC C -0.43%
REPL D -0.42%
ITOS B -0.41%
ALEC C -0.41%
ALLO D -0.41%
SVRA C -0.4%
URGN C -0.39%
APLT C -0.39%
ANNX C -0.37%
AVXL C -0.37%
CMPS D -0.36%
YMAB C -0.36%
FULC C -0.36%
AURA C -0.34%
TBPH C -0.33%
ALT F -0.31%
ACIU D -0.25%
VNDA C -0.24%
INZY C -0.24%
STRO C -0.24%
ENTA C -0.22%
ZNTL F -0.21%
ALDX D -0.16%
HLVX F -0.06%
Compare ETFs